Antigen-specific B cell receptor recognizing Streptococcus pneumoniae type 4 capsular polysaccharide (Anti-Pn4 BCR)

The antigen-specific B cell receptor (BCR) recognizing Streptococcus pneumoniae type 4 capsular polysaccharide is a membrane-bound immunoglobulin complex that serves as the primary sensor for this specific bacterial serotype [1.4.1]. It is composed of a surface-bound antibody associated with signaling subunits that trigger B cell activation upon binding to the capsular polysaccharide (CPS) [1.5.5]. The serotype 4 CPS is a complex tetrasaccharide polymer, and its recognition by the BCR often depends on specific structural features such as the pyruvate ketal modification [1.1.1, 1.1.3]. Engagement of the BCR by multivalent CPS antigens leads to receptor clustering and the initiation of signaling cascades involving kinases like SYK and BTK [1.2.1, 1.5.3]. This process is central to the efficacy of pneumococcal vaccines, including both pure polysaccharide and conjugate formulations, which aim to stimulate these specific B cell clones [1.4.1, 1.5.4]. Successful activation results in the production of high-affinity IgG and IgM antibodies that opsonize the pathogen for clearance by the innate immune system [1.4.1, 1.5.2]. Deficiencies in these specific BCR-mediated responses, whether due to age or medical treatments like B cell depletion therapy, significantly increase the risk of invasive pneumococcal disease [1.4.2, 1.4.4]. Consequently, this receptor is a critical focal point for vaccine design and the development of passive immunization strategies [1.3.1, 1.5.2].

Other names

Anti-pneumococcal serotype 4 B cell receptorStreptococcus pneumoniae serotype 4-specific BCRAnti-Pn4 BCRAnti-ST4 BCRB cell receptor for pneumococcal capsular polysaccharide type 4

Vaccine antigens bind to the specific B cell receptor, inducing receptor clustering and intracellular signaling that promotes B cell activation, clonal expansion, and differentiation into antibody-secreting plasma cells.